Tracking academic funding turbulence under Trump 2.0

The Trump administration has broken with decades of bipartisan support for biomedical research, launching a coordinated effort to shrink NIH’s grantmaking portfolio, curtail intramural research and reorient priorities. It has also taken the unprecedented step of using NIH funding as leverage to advance political and policy objectives unrelated to science or medicine, even when withholding funding creates risks for patients and threatens to disrupt medical progress.

Within its first 100 days, the administration has withdrawn or frozen billions of dollars in funding for U.S. academic researchers under the banners of opposing diversity, equity, inclusion and accessibility (DEI & A) ideology, punishing universities for their handling of campus protests, and increasing government efficiency by reducing spending. In biomedical research, NIH has been a focal point for the administration’s actions, via reductions in both the funds it disburses and in its own operations...